Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma

Author： Cruz J.C.   Alsina M.   Craig F.   Yoneda T.   Anderson J.L.   Dallas M.   Roodman G.D.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.29, Iss.4, 2001-04, pp. : 441-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myeloma bone disease

By Sezer Orhan  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 19-24

Maney Publishing

Access to resources Recommend Favorite

Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone - An in vitro model of Paget's disease

By Reddy S.V.   Menaa C.   Singer F.R.   Cundy T.   Cornish J.   Whyte M.P.   Roodman G.D.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1528-1532

Elsevier

Access to resources Recommend Favorite

Pycnodysostosis: Role and Regulation of Cathepsin K in Osteoclast Function and Human Disease

By  

Current Molecular Medicine, Vol. 2, Iss. 5, 2002-08 ,pp. : 407-421

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Apoptosis and Activity of the Osteoclast

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 100-107

Bentham Science Publishers

Access to resources Recommend Favorite

Disease model: human aging

By Kuro-o M.  

Trends in Molecular Medicine, Vol. 7, Iss. 4, 2001-04 ,pp. : 179-181

Elsevier

Access to resources Recommend Favorite